ReviewCNS drugs2026

Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD.

Monica Margoni et al.PubMed ↗Publisher ↗

No numbers read from the abstract.